acecainide has been researched along with Cerebrovascular Disorders in 1 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
Excerpt | Relevance | Reference |
---|---|---|
"Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug." | 3.66 | Long-term antiarrhythmic therapy with acetylprocainamide. ( Drayer, DE; Kluger, J; Leech, S; Lloyd, V; Reidenberg, MM, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kluger, J | 1 |
Leech, S | 1 |
Reidenberg, MM | 1 |
Lloyd, V | 1 |
Drayer, DE | 1 |
1 other study available for acecainide and Cerebrovascular Disorders
Article | Year |
---|---|
Long-term antiarrhythmic therapy with acetylprocainamide.
Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthritis, Rheum | 1981 |